Testing for Hereditary Breast Cancer: Panel or Targeted Testing? Experience from a Clinical Cancer Genetics Practice

Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment

(2014) Allison W. Kurian et al.   JOURNAL OF CLINICAL ONCOLOGY

The impact of next generation sequencing on the analysis of breast cancer susceptibility: a role for extremely rare genetic variation?

(2013) FSM Hilbers et al.   CLINICAL GENETICS

The integration of next-generation sequencing panels in the clinical cancer genetics practice: an institutional experience

(2013) Caitlin B. Mauer et al.   GENETICS IN MEDICINE

CDH1germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study

(2013) Patrick R Benusiglio et al.   JOURNAL OF MEDICAL GENETICS

Lifetime Cancer Risks in Individuals with Germline PTEN Mutations

(2012) M.-H. Tan et al.   CLINICAL CANCER RESEARCH

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility

(2010) Mark E. Robson et al.   JOURNAL OF CLINICAL ONCOLOGY

Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research

(2010) R. C. Fitzgerald et al.   JOURNAL OF MEDICAL GENETICS

Beyond Li Fraumeni Syndrome: Clinical Characteristics of Families Withp53Germline Mutations

(2009) Kelly D. Gonzalez et al.   JOURNAL OF CLINICAL ONCOLOGY

F18-Fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography Screening in Li-Fraumeni Syndrome

(2008) Serena Masciari   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION